Global Nuclear Medicine Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 25-Jun-2021
No. of pages: 107
Inquire Before Buying

Nuclear Medicine?or Radiopharmaceuticals? are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

The global average price of Nuclear Medicine is in the decreasing trend, from 41.6 USD/Dose in 2011 to 39.5 USD/Dose in 2015. With the situation of global economy, prices will be in decreasing trend in the following five years.

Market Analysis and Insights: Global Nuclear Medicine Market

The global Nuclear Medicine market size is projected to reach US$ 9498.6 million by 2027, from US$ 5762.7 million in 2020, at a CAGR of 7.4% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nuclear Medicine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nuclear Medicine market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nuclear Medicine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nuclear Medicine market.

Global Nuclear Medicine Scope and Market Size

Nuclear Medicine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nuclear Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Tc-99

- I-123/131

- In-111

- Xe-133

- Th-201

- Ga-67

- Others

Segment by Application

- Diagnostic

- Therapeutic

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- GE Healthcare

- Bracco Imaging

- Mallinckrodt

- Lantheus Medical Imaging

- Bayer

- Triad Isotopes

- Nordion

- Jubilant Pharma

- Eli Lilly

- SIEMENS

- China Isotope & Radiation

- Dongcheng

Global Nuclear Medicine Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nuclear Medicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tc-99
1.2.3 I-123/131
1.2.4 In-111
1.2.5 Xe-133
1.2.6 Th-201
1.2.7 Ga-67
1.2.8 Others
1.3 Market by Application
1.3.1 Global Nuclear Medicine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Diagnostic
1.3.3 Therapeutic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Nuclear Medicine Market Perspective (2016-2027)
2.2 Nuclear Medicine Growth Trends by Regions
2.2.1 Nuclear Medicine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Nuclear Medicine Historic Market Share by Regions (2016-2021)
2.2.3 Nuclear Medicine Forecasted Market Size by Regions (2022-2027)
2.3 Nuclear Medicine Industry Dynamic
2.3.1 Nuclear Medicine Market Trends
2.3.2 Nuclear Medicine Market Drivers
2.3.3 Nuclear Medicine Market Challenges
2.3.4 Nuclear Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nuclear Medicine Players by Revenue
3.1.1 Global Top Nuclear Medicine Players by Revenue (2016-2021)
3.1.2 Global Nuclear Medicine Revenue Market Share by Players (2016-2021)
3.2 Global Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Nuclear Medicine Revenue
3.4 Global Nuclear Medicine Market Concentration Ratio
3.4.1 Global Nuclear Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nuclear Medicine Revenue in 2020
3.5 Nuclear Medicine Key Players Head office and Area Served
3.6 Key Players Nuclear Medicine Product Solution and Service
3.7 Date of Enter into Nuclear Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nuclear Medicine Breakdown Data by Type
4.1 Global Nuclear Medicine Historic Market Size by Type (2016-2021)
4.2 Global Nuclear Medicine Forecasted Market Size by Type (2022-2027)
5 Nuclear Medicine Breakdown Data by Application
5.1 Global Nuclear Medicine Historic Market Size by Application (2016-2021)
5.2 Global Nuclear Medicine Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Nuclear Medicine Market Size (2016-2027)
6.2 North America Nuclear Medicine Market Size by Type
6.2.1 North America Nuclear Medicine Market Size by Type (2016-2021)
6.2.2 North America Nuclear Medicine Market Size by Type (2022-2027)
6.2.3 North America Nuclear Medicine Market Size by Type (2016-2027)
6.3 North America Nuclear Medicine Market Size by Application
6.3.1 North America Nuclear Medicine Market Size by Application (2016-2021)
6.3.2 North America Nuclear Medicine Market Size by Application (2022-2027)
6.3.3 North America Nuclear Medicine Market Size by Application (2016-2027)
6.4 North America Nuclear Medicine Market Size by Country
6.4.1 North America Nuclear Medicine Market Size by Country (2016-2021)
6.4.2 North America Nuclear Medicine Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Nuclear Medicine Market Size (2016-2027)
7.2 Europe Nuclear Medicine Market Size by Type
7.2.1 Europe Nuclear Medicine Market Size by Type (2016-2021)
7.2.2 Europe Nuclear Medicine Market Size by Type (2022-2027)
7.2.3 Europe Nuclear Medicine Market Size by Type (2016-2027)
7.3 Europe Nuclear Medicine Market Size by Application
7.3.1 Europe Nuclear Medicine Market Size by Application (2016-2021)
7.3.2 Europe Nuclear Medicine Market Size by Application (2022-2027)
7.3.3 Europe Nuclear Medicine Market Size by Application (2016-2027)
7.4 Europe Nuclear Medicine Market Size by Country
7.4.1 Europe Nuclear Medicine Market Size by Country (2016-2021)
7.4.2 Europe Nuclear Medicine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Nuclear Medicine Market Size (2016-2027)
8.2 Asia-Pacific Nuclear Medicine Market Size by Type
8.2.1 Asia-Pacific Nuclear Medicine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Nuclear Medicine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Nuclear Medicine Market Size by Type (2016-2027)
8.3 Asia-Pacific Nuclear Medicine Market Size by Application
8.3.1 Asia-Pacific Nuclear Medicine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Nuclear Medicine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Nuclear Medicine Market Size by Application (2016-2027)
8.4 Asia-Pacific Nuclear Medicine Market Size by Region
8.4.1 Asia-Pacific Nuclear Medicine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Nuclear Medicine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Nuclear Medicine Market Size (2016-2027)
9.2 Latin America Nuclear Medicine Market Size by Type
9.2.1 Latin America Nuclear Medicine Market Size by Type (2016-2021)
9.2.2 Latin America Nuclear Medicine Market Size by Type (2022-2027)
9.2.3 Latin America Nuclear Medicine Market Size by Type (2016-2027)
9.3 Latin America Nuclear Medicine Market Size by Application
9.3.1 Latin America Nuclear Medicine Market Size by Application (2016-2021)
9.3.2 Latin America Nuclear Medicine Market Size by Application (2022-2027)
9.3.3 Latin America Nuclear Medicine Market Size by Application (2016-2027)
9.4 Latin America Nuclear Medicine Market Size by Country
9.4.1 Latin America Nuclear Medicine Market Size by Country (2016-2021)
9.4.2 Latin America Nuclear Medicine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nuclear Medicine Market Size (2016-2027)
10.2 Middle East & Africa Nuclear Medicine Market Size by Type
10.2.1 Middle East & Africa Nuclear Medicine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Nuclear Medicine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Nuclear Medicine Market Size by Type (2016-2027)
10.3 Middle East & Africa Nuclear Medicine Market Size by Application
10.3.1 Middle East & Africa Nuclear Medicine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Nuclear Medicine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Nuclear Medicine Market Size by Application (2016-2027)
10.4 Middle East & Africa Nuclear Medicine Market Size by Country
10.4.1 Middle East & Africa Nuclear Medicine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Nuclear Medicine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Company Details
11.1.2 GE Healthcare Business Overview
11.1.3 GE Healthcare Nuclear Medicine Introduction
11.1.4 GE Healthcare Revenue in Nuclear Medicine Business (2016-2021)
11.1.5 GE Healthcare Recent Development
11.2 Bracco Imaging
11.2.1 Bracco Imaging Company Details
11.2.2 Bracco Imaging Business Overview
11.2.3 Bracco Imaging Nuclear Medicine Introduction
11.2.4 Bracco Imaging Revenue in Nuclear Medicine Business (2016-2021)
11.2.5 Bracco Imaging Recent Development
11.3 Mallinckrodt
11.3.1 Mallinckrodt Company Details
11.3.2 Mallinckrodt Business Overview
11.3.3 Mallinckrodt Nuclear Medicine Introduction
11.3.4 Mallinckrodt Revenue in Nuclear Medicine Business (2016-2021)
11.3.5 Mallinckrodt Recent Development
11.4 Lantheus Medical Imaging
11.4.1 Lantheus Medical Imaging Company Details
11.4.2 Lantheus Medical Imaging Business Overview
11.4.3 Lantheus Medical Imaging Nuclear Medicine Introduction
11.4.4 Lantheus Medical Imaging Revenue in Nuclear Medicine Business (2016-2021)
11.4.5 Lantheus Medical Imaging Recent Development
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer Nuclear Medicine Introduction
11.5.4 Bayer Revenue in Nuclear Medicine Business (2016-2021)
11.5.5 Bayer Recent Development
11.6 Triad Isotopes
11.6.1 Triad Isotopes Company Details
11.6.2 Triad Isotopes Business Overview
11.6.3 Triad Isotopes Nuclear Medicine Introduction
11.6.4 Triad Isotopes Revenue in Nuclear Medicine Business (2016-2021)
11.6.5 Triad Isotopes Recent Development
11.7 Nordion
11.7.1 Nordion Company Details
11.7.2 Nordion Business Overview
11.7.3 Nordion Nuclear Medicine Introduction
11.7.4 Nordion Revenue in Nuclear Medicine Business (2016-2021)
11.7.5 Nordion Recent Development
11.8 Jubilant Pharma
11.8.1 Jubilant Pharma Company Details
11.8.2 Jubilant Pharma Business Overview
11.8.3 Jubilant Pharma Nuclear Medicine Introduction
11.8.4 Jubilant Pharma Revenue in Nuclear Medicine Business (2016-2021)
11.8.5 Jubilant Pharma Recent Development
11.9 Eli Lilly
11.9.1 Eli Lilly Company Details
11.9.2 Eli Lilly Business Overview
11.9.3 Eli Lilly Nuclear Medicine Introduction
11.9.4 Eli Lilly Revenue in Nuclear Medicine Business (2016-2021)
11.9.5 Eli Lilly Recent Development
11.10 SIEMENS
11.10.1 SIEMENS Company Details
11.10.2 SIEMENS Business Overview
11.10.3 SIEMENS Nuclear Medicine Introduction
11.10.4 SIEMENS Revenue in Nuclear Medicine Business (2016-2021)
11.10.5 SIEMENS Recent Development
11.11 China Isotope & Radiation
11.11.1 China Isotope & Radiation Company Details
11.11.2 China Isotope & Radiation Business Overview
11.11.3 China Isotope & Radiation Nuclear Medicine Introduction
11.11.4 China Isotope & Radiation Revenue in Nuclear Medicine Business (2016-2021)
11.11.5 China Isotope & Radiation Recent Development
11.12 Dongcheng
11.12.1 Dongcheng Company Details
11.12.2 Dongcheng Business Overview
11.12.3 Dongcheng Nuclear Medicine Introduction
11.12.4 Dongcheng Revenue in Nuclear Medicine Business (2016-2021)
11.12.5 Dongcheng Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Nuclear Medicine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tc-99
Table 3. Key Players of I-123/131
Table 4. Key Players of In-111
Table 5. Key Players of Xe-133
Table 6. Key Players of Th-201
Table 7. Key Players of Ga-67
Table 8. Key Players of Others
Table 9. Global Nuclear Medicine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Nuclear Medicine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Nuclear Medicine Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Nuclear Medicine Market Share by Regions (2016-2021)
Table 13. Global Nuclear Medicine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Nuclear Medicine Market Share by Regions (2022-2027)
Table 15. Nuclear Medicine Market Trends
Table 16. Nuclear Medicine Market Drivers
Table 17. Nuclear Medicine Market Challenges
Table 18. Nuclear Medicine Market Restraints
Table 19. Global Nuclear Medicine Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Nuclear Medicine Market Share by Players (2016-2021)
Table 21. Global Top Nuclear Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine as of 2020)
Table 22. Ranking of Global Top Nuclear Medicine Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Nuclear Medicine Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Nuclear Medicine Product Solution and Service
Table 26. Date of Enter into Nuclear Medicine Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Nuclear Medicine Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Nuclear Medicine Revenue Market Share by Type (2016-2021)
Table 30. Global Nuclear Medicine Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Nuclear Medicine Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Nuclear Medicine Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Nuclear Medicine Revenue Market Share by Application (2016-2021)
Table 34. Global Nuclear Medicine Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Nuclear Medicine Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Nuclear Medicine Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Nuclear Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Nuclear Medicine Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Nuclear Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Nuclear Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Nuclear Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Nuclear Medicine Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Nuclear Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Nuclear Medicine Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Nuclear Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Nuclear Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Nuclear Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Nuclear Medicine Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Nuclear Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Nuclear Medicine Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Nuclear Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Nuclear Medicine Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Nuclear Medicine Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Nuclear Medicine Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Nuclear Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Nuclear Medicine Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Nuclear Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Nuclear Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Nuclear Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Nuclear Medicine Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Nuclear Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Nuclear Medicine Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Nuclear Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Nuclear Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Nuclear Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 66. GE Healthcare Company Details
Table 67. GE Healthcare Business Overview
Table 68. GE Healthcare Nuclear Medicine Product
Table 69. GE Healthcare Revenue in Nuclear Medicine Business (2016-2021) & (US$ Million)
Table 70. GE Healthcare Recent Development
Table 71. Bracco Imaging Company Details
Table 72. Bracco Imaging Business Overview
Table 73. Bracco Imaging Nuclear Medicine Product
Table 74. Bracco Imaging Revenue in Nuclear Medicine Business (2016-2021) & (US$ Million)
Table 75. Bracco Imaging Recent Development
Table 76. Mallinckrodt Company Details
Table 77. Mallinckrodt Business Overview
Table 78. Mallinckrodt Nuclear Medicine Product
Table 79. Mallinckrodt Revenue in Nuclear Medicine Business (2016-2021) & (US$ Million)
Table 80. Mallinckrodt Recent Development
Table 81. Lantheus Medical Imaging Company Details
Table 82. Lantheus Medical Imaging Business Overview
Table 83. Lantheus Medical Imaging Nuclear Medicine Product
Table 84. Lantheus Medical Imaging Revenue in Nuclear Medicine Business (2016-2021) & (US$ Million)
Table 85. Lantheus Medical Imaging Recent Development
Table 86. Bayer Company Details
Table 87. Bayer Business Overview
Table 88. Bayer Nuclear Medicine Product
Table 89. Bayer Revenue in Nuclear Medicine Business (2016-2021) & (US$ Million)
Table 90. Bayer Recent Development
Table 91. Triad Isotopes Company Details
Table 92. Triad Isotopes Business Overview
Table 93. Triad Isotopes Nuclear Medicine Product
Table 94. Triad Isotopes Revenue in Nuclear Medicine Business (2016-2021) & (US$ Million)
Table 95. Triad Isotopes Recent Development
Table 96. Nordion Company Details
Table 97. Nordion Business Overview
Table 98. Nordion Nuclear Medicine Product
Table 99. Nordion Revenue in Nuclear Medicine Business (2016-2021) & (US$ Million)
Table 100. Nordion Recent Development
Table 101. Jubilant Pharma Company Details
Table 102. Jubilant Pharma Business Overview
Table 103. Jubilant Pharma Revenue in Nuclear Medicine Business (2016-2021) & (US$ Million)
Table 104. Jubilant Pharma Recent Development
Table 105. Eli Lilly Company Details
Table 106. Eli Lilly Business Overview
Table 107. Eli Lilly Nuclear Medicine Product
Table 108. Eli Lilly Revenue in Nuclear Medicine Business (2016-2021) & (US$ Million)
Table 109. Eli Lilly Recent Development
Table 110. SIEMENS Company Details
Table 111. SIEMENS Business Overview
Table 112. SIEMENS Nuclear Medicine Product
Table 113. SIEMENS Revenue in Nuclear Medicine Business (2016-2021) & (US$ Million)
Table 114. SIEMENS Recent Development
Table 115. China Isotope & Radiation Company Details
Table 116. China Isotope & Radiation Business Overview
Table 117. China Isotope & Radiation Nuclear Medicine Product
Table 118. China Isotope & Radiation Revenue in Nuclear Medicine Business (2016-2021) & (US$ Million)
Table 119. China Isotope & Radiation Recent Development
Table 120. Dongcheng Company Details
Table 121. Dongcheng Business Overview
Table 122. Dongcheng Nuclear Medicine Product
Table 123. Dongcheng Revenue in Nuclear Medicine Business (2016-2021) & (US$ Million)
Table 124. Dongcheng Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nuclear Medicine Market Share by Type: 2020 VS 2027
Figure 2. Tc-99 Features
Figure 3. I-123/131 Features
Figure 4. In-111 Features
Figure 5. Xe-133 Features
Figure 6. Th-201 Features
Figure 7. Ga-67 Features
Figure 8. Others Features
Figure 9. Global Nuclear Medicine Market Share by Application: 2020 VS 2027
Figure 10. Diagnostic Case Studies
Figure 11. Therapeutic Case Studies
Figure 12. Nuclear Medicine Report Years Considered
Figure 13. Global Nuclear Medicine Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Nuclear Medicine Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Nuclear Medicine Market Share by Regions: 2020 VS 2027
Figure 16. Global Nuclear Medicine Market Share by Regions (2022-2027)
Figure 17. Global Nuclear Medicine Market Share by Players in 2020
Figure 18. Global Top Nuclear Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Nuclear Medicine Revenue in 2020
Figure 20. Global Nuclear Medicine Revenue Market Share by Type (2016-2021)
Figure 21. Global Nuclear Medicine Revenue Market Share by Type (2022-2027)
Figure 22. North America Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Nuclear Medicine Market Share by Type (2016-2027)
Figure 24. North America Nuclear Medicine Market Share by Application (2016-2027)
Figure 25. North America Nuclear Medicine Market Share by Country (2016-2027)
Figure 26. United States Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Nuclear Medicine Market Share by Type (2016-2027)
Figure 30. Europe Nuclear Medicine Market Share by Application (2016-2027)
Figure 31. Europe Nuclear Medicine Market Share by Country (2016-2027)
Figure 32. Germany Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Nuclear Medicine Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Nuclear Medicine Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Nuclear Medicine Market Share by Region (2016-2027)
Figure 42. China Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Nuclear Medicine Market Share by Type (2016-2027)
Figure 50. Latin America Nuclear Medicine Market Share by Application (2016-2027)
Figure 51. Latin America Nuclear Medicine Market Share by Country (2016-2027)
Figure 52. Mexico Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Nuclear Medicine Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Nuclear Medicine Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Nuclear Medicine Market Share by Country (2016-2027)
Figure 58. Turkey Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. GE Healthcare Revenue Growth Rate in Nuclear Medicine Business (2016-2021)
Figure 62. Bracco Imaging Revenue Growth Rate in Nuclear Medicine Business (2016-2021)
Figure 63. Mallinckrodt Revenue Growth Rate in Nuclear Medicine Business (2016-2021)
Figure 64. Lantheus Medical Imaging Revenue Growth Rate in Nuclear Medicine Business (2016-2021)
Figure 65. Bayer Revenue Growth Rate in Nuclear Medicine Business (2016-2021)
Figure 66. Triad Isotopes Revenue Growth Rate in Nuclear Medicine Business (2016-2021)
Figure 67. Nordion Revenue Growth Rate in Nuclear Medicine Business (2016-2021)
Figure 68. Jubilant Pharma Revenue Growth Rate in Nuclear Medicine Business (2016-2021)
Figure 69. Eli Lilly Revenue Growth Rate in Nuclear Medicine Business (2016-2021)
Figure 70. SIEMENS Revenue Growth Rate in Nuclear Medicine Business (2016-2021)
Figure 71. China Isotope & Radiation Revenue Growth Rate in Nuclear Medicine Business (2016-2021)
Figure 72. Dongcheng Revenue Growth Rate in Nuclear Medicine Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
  • Global Nuclear Medicine Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106
    According to our LPI (LP Information) latest study, the global Nuclear Medicine market size was valued at US$ 6054.6 million in 2023. With growing demand in downstream market, the Nuclear Medicine is forecast to a readjusted size of US$ 10160 million by 2030 with a CAGR of 7.7% during review period. The research report highlights the growth potential of the global Nuclear Medicine market. Nuclear Medicine are expected to show stable growth in the future market. However, product different......
  • Global Nuclear Imaging Equipment Market Research Report 2023, Forecast to 2028
    Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 138
    Nuclear medicine uses a special gamma camera and single-photon emission-computed tomography (SPECT) imaging techniques. The gamma camera records the energy emissions from the radiotracer in your body and converts it into an image. The gamma camera itself does not emit any radiation. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each seg......
  • Global Nuclear Imaging Equipment Professional Survey Report 2023, Forecast to 2028
    Published: 28-Dec-2023        Price: US 3280 Onwards        Pages: 107
    Nuclear medicine uses a special gamma camera and single-photon emission-computed tomography (SPECT) imaging techniques. The gamma camera records the energy emissions from the radiotracer in your body and converts it into an image. The gamma camera itself does not emit any radiation. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each seg......
  • Global Gamma Camera Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 104
    Market Overview of Global Gamma Camera market: According to our latest research, the global Gamma Camera market looks promising in the next 5 years. As of 2022, the global Gamma Camera market was estimated at USD 622.4 million, and it's anticipated to reach USD 742.27 million in 2028, with a CAGR of 2.98% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Gamma Camera market, with ......
  • Global Nuclear Imaging Equipment Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 19-Dec-2023        Price: US 3380 Onwards        Pages: 101
    Market Overview of Global Nuclear Imaging Equipment market: According to our latest research, the global Nuclear Imaging Equipment market looks promising in the next 5 years. As of 2022, the global Nuclear Imaging Equipment market was estimated at USD 3813.05 million, and it's anticipated to reach USD 5077.36 million in 2028, with a CAGR of 4.89% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......
  • Global Nuclear Medicine Equipment Market Research Report 2023
    Published: 14-Dec-2023        Price: US 2900 Onwards        Pages: 93
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Nuclear Medicine Equipment market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Philips - Siemens - Digirad - Mediso Medical Imaging Systems - Toshiba - Bozlu - Neusoft - Compañía Mexicana - SurgicE......
  • Global Nuclear Imaging Systems Market Research Report 2023
    Published: 14-Dec-2023        Price: US 2900 Onwards        Pages: 97
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Nuclear Imaging Systems market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - GE Healthcare - Siemens Healthcare - Philips Healthcare - Canon Medical Systems - Hitachi Medical - Digirad Corporation - DDD-Diagnosti......
  • Global Nuclear Medicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 105
    Market Overview of Global Nuclear Medicine market: According to our latest research, the global Nuclear Medicine market looks promising in the next 5 years. As of 2022, the global Nuclear Medicine market was estimated at USD 4471.65 million, and it's anticipated to reach USD 7074.48 million in 2028, with a CAGR of 7.95% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nuclear Med......
  • Global Nuclear Imaging Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Nov-2023        Price: US 3380 Onwards        Pages: 104
    Market Overview of Global Nuclear Imaging market: According to our latest research, the global Nuclear Imaging market looks promising in the next 5 years. As of 2022, the global Nuclear Imaging market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nuclear Imaging market, wi......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs